PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

• Strengthens position to become a leader in the intradermal delivery of FDA prescription-based ketamine products
  
• Supports commercializing novel uses and delivery methods of psychedelics

Read More